EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Hepatoprotective Activity of Serinolamide A against Paracetamol-Induced Hepatotoxicity in Rats

Prajita J. Tayade, Sujal R. Jaiswal, Sayli A. Tekade, Deepak Mohale, Jagdish V. Manwar, Minakshee G. Nimbalwar, Ganesh R. Pawar

International Journal of Drug Delivery Technology · 16.07.2026 · 16 (65s)

DOI: 10.25258/ijddt.16.65s.72 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.07.2026. Verfasst von Prajita J. Tayade und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paracetamol-induced hepatotoxicity is characterized by oxidative stress, inflammatory responses, and progressive liver damage. The present study aimed to evaluate the hepatoprotective effects of Serinolamide A against paracetamol-induced hepatotoxicity in rats. Experimental hepatotoxicity was induced by paracetamol administration, and rats were treated orally with Serinolamide A (1, 5, and 10 mg/kg) for 28 consecutive days. Liv52 (70 mg/kg, p.o.) was used as the standard drug. Body weight, liver weight, serum biochemical parameters, oxidative stress markers, pro-inflammatory cytokines, and histopathological changes were evaluated. Treatment with Serinolamide A significantly ameliorated paracetamolinduced alterations and restored body and liver weights. Furthermore, Serinolamide A enhanced antioxidant defense by increasing superoxide dismutase, catalase, and reduced glutathione activities and reduced lipid peroxidation. The treatment also attenuated inflammatory responses by decreasing tumor necrosis factor-α and interleukin-6 levels. Histopathological examination revealed marked protection against paracetamol-induced hepatic damage. The observed effects were dose-dependent, with the 10 mg/kg dose showing effects comparable to those of Liv52. These findings suggest that Serinolamide A possesses significant hepatoprotective activity, which may be attributed to its antioxidant and anti-inflammatory properties, and could represent a promising therapeutic candidate for the management of drug-induced liver injury

Zitieren

APA

Tayade, P. J., Jaiswal, S. R., Tekade, S. A., Mohale, D., Manwar, J. V., Nimbalwar, M. G., & Pawar, G. R. (2026). Evaluation of the Hepatoprotective Activity of Serinolamide A against Paracetamol-Induced Hepatotoxicity in Rats. International Journal of Drug Delivery Technology, 16(65s). https://doi.org/10.25258/ijddt.16.65s.72

Vancouver

Tayade PJ, Jaiswal SR, Tekade SA, Mohale D, Manwar JV, Nimbalwar MG, et al. Evaluation of the Hepatoprotective Activity of Serinolamide A against Paracetamol-Induced Hepatotoxicity in Rats. International Journal of Drug Delivery Technology. 2026;16(65s). doi:10.25258/ijddt.16.65s.72

BibTeX
@article{Tayade2026,
  author = {Tayade, Prajita J. and Jaiswal, Sujal R. and Tekade, Sayli A. and Mohale, Deepak and Manwar, Jagdish V. and Nimbalwar, Minakshee G. and Pawar, Ganesh R.},
  title = {Evaluation of the Hepatoprotective Activity of Serinolamide A against Paracetamol-Induced Hepatotoxicity in Rats},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {65s},
  doi = {10.25258/ijddt.16.65s.72}
}
Kostenlos starten →